Breast Cancer Stem-Like Cells are inhibited by diosgenin, a steroidal saponin, by the attenuation of the Wnt b-Catenin signaling via the Wnt antagonist secreted frizzled related Protein-4

Bhuvanalakshmi, GB and Warrier, Sudha R (2017) Breast Cancer Stem-Like Cells are inhibited by diosgenin, a steroidal saponin, by the attenuation of the Wnt b-Catenin signaling via the Wnt antagonist secreted frizzled related Protein-4. Frontiers in Pharmacology, 8. pp. 124-138. ISSN 1663-9812

[img] PDF
RMS - 00006676.pdf - Published Version
Restricted to Registered users only

Download (5MB) | Request a copy

Abstract

Background: Identification of breast cancer stem cells as the chemo-resistant and tumor-initiating population represents an important milestone in approaching anticancer therapies. Targeting this minor subpopulation of chemo- and radio-resistant stem-like cells, termed as the cancer stem cells (CSCs) and their eradication could significantly enhance clinical outcomes. Most of the presently administered chemotherapeutics target the tumor bulk but are ineffective against the CSCs. We report here that diosgenin (DG), a naturally occurring steroidal saponin, could effectively inhibit CSCs from three breast cancer cell lines, MCF7, T47D and MDA-MB-231, by inducing apoptosis and inhibiting the CSC associated phenotypes. Methods: CSCs were enriched in these cells lines, characterized for CSC traits by immunocytochemistry and flow cytometry. Proliferation and apoptosis assays were performed in these breast CSCs in the presence of DG to obtain the inhibitory concentration. Apoptosis was confirmed with gene expression analysis, Western blotting and propidium iodide staining. TCF-LEF reporter assay, sFRP overexpression and RNAi silencing studies were performed to study regulation of the Wnt pathway. Statistical significance was evaluated by a two-sided Student’s t-test. Results: Using the TCF-LEF reporter system, we show the effect of DG on CSCs is predominantly through the network regulating CSC self renewal, the Wnt b-catenin pathway. Specifically, the Wnt antagonist, the secreted frizzled related protein 4, (sFRP4), had a defining role in the action of DG. Gain-of-function of sFRP4 in CSCs could improve the response to DG wherein CSC mediators were inhibited, b-catenin was down regulated and the effectors of epithelial to mesenchymal transition and pro-invasive markers were repressed. Conversely, the loss-of-function of sFRP4 had a reverse effect on the CSC population which therein became enriched, their response to DG treatment was modest, b-catenin levels increased, GSK3b expression decreased and the expression of epithelial markers of CSC was completely abrogated. Conclusion: These findings demonstrate the effect of DG on inhibiting the resilient breast CSCs which could provide a benchmark for the development of DG-based therapies in breast cancer treatment.

Item Type: Article
Uncontrolled Keywords: Breast cancer stem cells; diosgenin; Wnt antagonists; sFRP4; EMT.
Subjects: Regenerative Medicine > MIRM Bangalore
Depositing User: MCON Library
Date Deposited: 10 Jun 2019 06:03
Last Modified: 10 Jun 2019 06:03
URI: http://eprints.manipal.edu/id/eprint/153934

Actions (login required)

View Item View Item